IPO registrations (S-1, F-1) · Registrants
Starling Oncology, Inc.
- SEC CIK
- 1799191 · filings on EDGAR ↗
- Name on the registration
- Oncology Institute, Inc.
- Former names
- Oncology Institute, Inc. (2021–2026); DFP HEALTHCARE ACQUISITIONS CORP. (2020–2021)
- Registration
- Form S-1, first filed 2020-02-21, last 2022-09-23; 4 initial registrations, 4 amendments
- Outcome
- Final prospectus filed 2020-03-12; declared effective 2020-03-10
- Industry (SIC)
- Services-Offices & Clinics of Doctors of Medicine 8011
- Incorporated in
- DE
- Business address
- 18000 STUDEBAKER RD, SUITE 800, Cerritos, CA 90703
- EIN
- 84-3562323
- Ticker
- STLN, DFPH, STLNW (Nasdaq, OTC, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Starling Oncology, Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2020-03-12, an initial public offering)
- Shares sold
- 20,000,000
- Gross proceeds
- $200,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol DFPH
- Lead underwriters
- Deutsche Bank; Jefferies; UBS
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Oncology Institute, Inc. EXACT (CIK (EXACT))
- SEC filer: DFP HEALTHCARE ACQUISITIONS CORP. EXACT (CIK (EXACT))
- Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther))
Filings 18
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-02-21 | S-1 | S-1 (registration) | DFP HEALTHCARE ACQUISITIONS CORP. | 0001047469-20-000999 ↗ |
| 2020-03-04 | S-1/A | S-1/A (amendment) | DFP HEALTHCARE ACQUISITIONS CORP. | 0001047469-20-001186 ↗ |
| 2020-03-05 | S-1/A | S-1/A (amendment) | DFP HEALTHCARE ACQUISITIONS CORP. | 0001047469-20-001255 ↗ |
| 2020-03-10 | EFFECT | EFFECT (declared effective) | DFP HEALTHCARE ACQUISITIONS CORP. | 9999999995-20-000536 ↗ |
| 2020-03-12 | 424B4 | 424B4 (final prospectus) | DFP HEALTHCARE ACQUISITIONS CORP. | 0001047469-20-001429 ↗ |
| 2021-10-22 | EFFECT | EFFECT (declared effective) | DFP HEALTHCARE ACQUISITIONS CORP. | 9999999995-21-004000 ↗ |
| 2021-12-17 | S-1 | S-1 (registration) | Oncology Institute, Inc. | 0001104659-21-151234 ↗ |
| 2022-02-09 | S-1/A | S-1/A (amendment) | Oncology Institute, Inc. | 0001104659-22-014401 ↗ |
| 2022-02-11 | EFFECT | EFFECT (declared effective) | Oncology Institute, Inc. | 9999999995-22-000420 ↗ |
| 2022-05-03 | EFFECT | EFFECT (declared effective) | Oncology Institute, Inc. | 9999999995-22-001286 ↗ |
| 2022-05-19 | S-1 | S-1 (registration) | Oncology Institute, Inc. | 0001104659-22-062776 ↗ |
| 2022-06-03 | EFFECT | EFFECT (declared effective) | Oncology Institute, Inc. | 9999999995-22-001683 ↗ |
| 2022-09-08 | S-1 | S-1 (registration) | Oncology Institute, Inc. | 0001628280-22-024554 ↗ |
| 2022-09-23 | S-1/A | S-1/A (amendment) | Oncology Institute, Inc. | 0001628280-22-025415 ↗ |
| 2022-09-26 | EFFECT | EFFECT (declared effective) | Oncology Institute, Inc. | 9999999995-22-002827 ↗ |
| 2023-01-06 | EFFECT | EFFECT (declared effective) | Oncology Institute, Inc. | 9999999995-23-000049 ↗ |
| 2023-02-09 | EFFECT | EFFECT (declared effective) | Oncology Institute, Inc. | 9999999995-23-000345 ↗ |
| 2023-02-09 | EFFECT | EFFECT (declared effective) | Oncology Institute, Inc. | 9999999995-23-000348 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-03-04 | S-1/A | registration statement | $10.00 | 20,000,000 | $200,000,000 | Nasdaq DFPH | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ | |
| 2020-03-05 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2020-03-12 | 424B4 | final prospectus | $10.00 | 20,000,000 | $200,000,000 | Nasdaq DFPH | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BARASCH RICHARD A | Director; Director,Officer | Executive Chairman | 18 | 2020–2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Director,TenPercentOwnerOther; TenPercentOwnerOther | 3 | 2020–2021 | ||
| Deerfield Mgmt IV, L.P. | Director,TenPercentOwnerOther; TenPercentOwnerOther | 3 | 2020–2021 | ||
| Deerfield Mgmt L.P. | Director,TenPercentOwnerOther; TenPercentOwnerOther | 3 | 2020–2021 | ||
| DEERFIELD PARTNERS, L.P. | Director,TenPercentOwnerOther; TenPercentOwnerOther | 3 | 2020–2021 | ||
| Deerfield Private Design Fund IV, L.P. | Director,TenPercentOwnerOther; TenPercentOwnerOther | 3 | 2020–2021 | ||
| Flynn James E | Director,TenPercentOwnerOther; TenPercentOwnerOther | 3 | 2020–2021 | person page Fuzzy | |
| HOCHBERG STEVEN | Director,Officer,TenPercentOwner; TenPercentOwnerOther | President and CEO | 2 | 2020–2021 | |
| Kaushal Mohit | Director | 13 | 2020–2026 | ||
| Sorensen Gregory | Director | 1 | 2020 | ||
| Wolfe Chris | Officer | Chief Financial Officer | 1 | 2020 | |
| Atinsky Lawrence | Director,TenPercentOwner; TenPercentOwnerOther | Director by Deputization | 2 | 2020–2021 | |
| DFP Sponsor LLC | Director,TenPercentOwner; TenPercentOwnerOther | Director by Deputization | 2 | 2020–2021 | |
| Carter Jennifer L. | Director | 1 | 2020 | ||
| Dalgleish Scott | Officer | Chief Financial Officer | 4 | 2021–2022 | |
| Hively Brad | Director; Director,Officer; Officer | Chief Executive Officer | 25 | 2021–2026 | |
| Johnson Karen Marie | Director | 9 | 2021–2026 | ||
| McGeorge Anne | Director | 8 | 2021–2026 | ||
| O'Meara Maeve | Director | 5 | 2021–2023 | ||
| OncologyCare Partners, LLC | Director | 1 | 2021 | ||
| Podnos Yale | Officer | Chief Medical Officer | 24 | 2021–2026 | |
| SARIN RAVI YANG | Director | 6 | 2021–2023 | ||
| Virnich Daniel | Officer | Chief Executive Officer; Chief Operating Officer; President | 23 | 2021–2026 | |
| Havencrest Healthcare Partners GP, LLC | TenPercentOwner | 27 | 2021–2024 | ||
| Havencrest Healthcare Partners, L.P. | TenPercentOwner | 27 | 2021–2024 | ||
| M33 Growth I GP LLC | Director; Director,TenPercentOwner; TenPercentOwner | 6 | 2021–2025 | ||
| M33 Growth I L.P. | Director; Director,TenPercentOwner; TenPercentOwner | 6 | 2021–2025 | ||
| TOI HC I, LLC | TenPercentOwner | 27 | 2021–2024 | ||
| TOI M, LLC | Director; Director,TenPercentOwner; TenPercentOwner | 5 | 2021–2025 | ||
| Agajanian Richy | TenPercentOwner | 3 | 2021–2022 | ||
| Jimmy Holdings, Inc. | TenPercentOwner | 3 | 2021–2022 | ||
| Miller Matthew P | Officer | Chief Operating Officer | 9 | 2022–2023 | |
| Shah Mihir | Officer; OfficerOther | Chief Financial Officer | 7 | 2022–2024 | |
| Simoneit Diona | Officer; OfficerOther | Chief Accounting Officer | 4 | 2022 | |
| Ling Gabriel | Director | 7 | 2022–2025 | ||
| Pacala Mark L | Director | 10 | 2022–2026 | ||
| Castle Jeremy | Officer | Chief Operating Officer; Chief Operations Officer | 8 | 2023–2025 | |
| Carter Robert Ross | Officer | Chief Financial Officer | 13 | 2024–2026 | |
| Langsam Jeffrey | Officer | Chief Clinical Officer | 4 | 2025–2026 | |
| England Kristin | Officer | Chief Administrative Officer | 4 | 2025–2026 | |
| STOLPER MARK | Director | 3 | 2026 | ||
| Chernett Jorey | TenPercentOwner | 14 | 2026 | ||
| TZOUMAKAS KIMBERLY JO | Director | 3 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-04-08 | Oncology Institute, Inc. | Hospitals and Physicians | $16,444,699 | $16,444,699 | 14 | 1 |
| 2022-08-24 | Oncology Institute, Inc. | Hospitals and Physicians | $110,000,000 | $110,000,000 | 3 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Oncology Institute, Inc. | CA | Form D private offerings | CIK (EXACT) |
| Nonprofit | STARLING ONCOLOGY FOUNDATION | CA | Nonprofits (IRS Form 990) | same street address and ZIP code, 18000 STUDEBAKER RD STE 800 90703 (FUZZY: a shared address, not proof of a shared organization) |
| SEC filer | Starling Oncology, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | James E Flynn | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Offices & Clinics of Doctors of Medicine, CA first:
- PROSPECT MEDICAL HOLDINGS INC CA
- 1Life Healthcare Inc CA
- Hims & Hers Health, Inc. CA
- SBC Medical Group Holdings Inc CA
- WELLQUEST MEDICAL & WELLNESS CORP AR
- ETAO International Co., Ltd. E9
- iKang Healthcare Group, Inc. F4
- METROPOLITAN HEALTH NETWORKS INC FL
- COAST DENTAL SERVICES INC FL
- RADIATION THERAPY SERVICES, INC. FL
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Services-Offices & Clinics of Doctors of Medicine · Health